Sa1086 Dose Escalation of Vedolizumab From Every 8 Weeks to Every 4 or 6 Weeks Enables Patients With Inflammatory Bowel Disease to Recapture Response
| Autor: | Ladd, Antonio H. Mendoza, Scott, Frank I., Grace, Rory, Bownik, Hillary, Lichtenstein, Gary R. |
|---|---|
| Zdroj: | In Gastroenterology April 2016 150(4) Supplement 1:S235-S236 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|